Private prison operator CoreCivic (NYSE:CXW) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 27.3% year on year to $684.9 million. Its non-GAAP profit of $0.38 per share was 11.8% above analysts’ consensus estimates.
Is now the time to buy CXW? Find out in our full research report (it’s free for active Edge members).
CoreCivic (CXW) Q2 CY2026 Highlights:
- Revenue: $684.9 million vs analyst estimates of $617.7 million (27.3% year-on-year growth, 10.9% beat)
- Adjusted EPS: $0.38 vs analyst estimates of $0.34 (11.8% beat)
- Adjusted EBITDA: $109.4 million vs analyst estimates of $108.4 million (16% margin, 0.9% beat)
- Management raised its full-year Adjusted EPS guidance to $1.66 at the midpoint, a 5.1% increase
- EBITDA guidance for the full year is $443 million at the midpoint, below analyst estimates of $454.1 million
- Operating Margin: 10.1%, down from 12% in the same quarter last year
- Market Capitalization: $3.09 billion
StockStory’s Take
CoreCivic’s second quarter was marked by strong revenue growth and outperformance relative to Wall Street expectations, with management citing increased occupancy rates and higher demand from its federal government partners as primary drivers. CEO Patrick Swindle highlighted the significant activation of previously idle facilities and the completion of new management contracts, particularly with U.S. Immigration and Customs Enforcement (ICE). The quarter also benefited from the acquisition of Clinical Solutions Pharmacy and contributions from new contracts, as well as a favorable shift in revenue mix toward ICE-related services.
Looking ahead, management’s updated outlook is anchored by expectations of gradually rising detention populations and further facility activations, particularly as ICE enforcement activity regains momentum. CFO David Garfinkle noted that updated guidance reflects both the impact of recent asset sales and the potential for modified management contracts, while also incorporating higher incentive compensation and incremental demand from federal partners. Management emphasized that the expanded share repurchase program and improved liquidity provide flexibility for both capital allocation and potential further growth initiatives.
Key Insights from Management’s Remarks
CoreCivic’s second quarter results were shaped by increased ICE activity, strategic asset sales, and the ramp-up of key facilities, which also influenced the company’s updated guidance and capital deployment plans.
ICE demand resurgence: Management reported a notable rise in ICE detainee populations, which drove higher occupancy at key facilities and led to a 51.6% increase in ICE-related revenue versus the prior year. CEO Patrick Swindle emphasized that “nationwide ICE detention populations increased to 65.5 thousand in early July,” reflecting the agency’s renewed enforcement activity after a temporary decline.
New facility activations: Several previously idle facilities, including the Prairie Correctional Facility and California City Detention Facility, were reactivated under new or expanded contracts, contributing to higher overall occupancy. Swindle noted that these activations required substantial upfront investment but are expected to generate incremental revenue as occupancy ramps through the remainder of the year.
Strategic asset sales: The sale of four detention facilities to government buyers generated approximately $1.6 billion in net proceeds, which management plans to use for debt reduction and share repurchases. Swindle stated that these sales “fortify our already strong financial position and create significant balance sheet flexibility.”
Segment realignment: CoreCivic redefined its operating segments to better reflect business operations, with the new Services segment gaining importance following the acquisition of Clinical Solutions Pharmacy. This segment now delivers pharmaceutical, transportation, and monitoring services, contributing to a more diversified revenue mix.
Margin compression and mix shift: Despite higher revenue, operating margins declined year-on-year, driven by lower ICE occupancy in part of the quarter, start-up costs at newly activated facilities, and a mix shift between federal contracts. Garfinkle expects margins to improve as newly activated facilities reach higher occupancy and contract terms are renegotiated.
Drivers of Future Performance
CoreCivic’s outlook is shaped by rising federal and state demand, new facility ramp-ups, and the expanded share buyback program, though contract renegotiations and occupancy trends remain key variables.
ICE population trends: Management expects ICE populations in CoreCivic’s care to increase in the second half of the year, following recent nationwide trends. This is projected to support higher occupancy and utilization at facilities brought online in the past year, offsetting earlier temporary declines. However, the pace of growth will depend on ongoing government enforcement activity and macro policy shifts.
Contract renewal and asset sale negotiations: The financial impact of recently sold facilities is subject to contract renegotiations with government partners. Garfinkle noted that updated guidance incorporates a range of potential outcomes from these negotiations, which could affect both revenue and margins in future quarters. Ongoing preliminary discussions about additional asset sales may also create variability in capital allocation and earnings visibility.
Capital allocation flexibility: With significant cash proceeds from asset sales, CoreCivic plans to accelerate share repurchases and continue reducing debt. Management emphasized that the company’s leverage ratio now provides ample room to deploy capital for shareholder returns or for opportunistic acquisitions, but the timing will be influenced by blackout windows and the status of ongoing negotiations.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will be monitoring (1) the pace at which newly activated facilities reach target occupancy and contribute to margins, (2) the outcome of contract renegotiations following recent asset sales and their effect on revenue visibility, and (3) CoreCivic’s ability to deploy capital through the expanded share repurchase program without disrupting leverage targets. Further developments in ICE enforcement and potential new asset sales could also influence long-term strategic direction.
CoreCivic currently trades at $32.06, up from $31.23 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).
Our Favorite Stocks Right Now
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.